Dolores Keating

505 total citations
23 papers, 275 citations indexed

About

Dolores Keating is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and General Health Professions. According to data from OpenAlex, Dolores Keating has authored 23 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 9 papers in Geriatrics and Gerontology and 7 papers in General Health Professions. Recurrent topics in Dolores Keating's work include Schizophrenia research and treatment (14 papers), Pharmaceutical Practices and Patient Outcomes (9 papers) and Bipolar Disorder and Treatment (5 papers). Dolores Keating is often cited by papers focused on Schizophrenia research and treatment (14 papers), Pharmaceutical Practices and Patient Outcomes (9 papers) and Bipolar Disorder and Treatment (5 papers). Dolores Keating collaborates with scholars based in Ireland, United Kingdom and Australia. Dolores Keating's co-authors include Stephen McWilliams, Mary Clarke, Judith Strawbridge, Gráinne Cousins, Ian Schneider, Anthony Kinsella, Fiona Boland, Mark Taylor, Roisin Doyle and Erin K. Crowley and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Schizophrenia Bulletin.

In The Last Decade

Dolores Keating

19 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dolores Keating Ireland 8 203 65 52 35 34 23 275
Peter H. Hilderink Netherlands 8 186 0.9× 84 1.3× 65 1.3× 45 1.3× 22 0.6× 13 298
Wulf‐Peter Hansen Germany 9 238 1.2× 64 1.0× 102 2.0× 35 1.0× 50 1.5× 17 318
Alex Su Singapore 8 221 1.1× 52 0.8× 93 1.8× 17 0.5× 58 1.7× 15 289
Mallik Greene United States 11 455 2.2× 64 1.0× 92 1.8× 23 0.7× 66 1.9× 49 563
Sainza García Spain 6 218 1.1× 26 0.4× 73 1.4× 12 0.3× 37 1.1× 8 346
Ivano Caselli Italy 10 129 0.6× 30 0.5× 86 1.7× 20 0.6× 58 1.7× 37 278
Marta Ielmini Italy 10 140 0.7× 30 0.5× 132 2.5× 33 0.9× 67 2.0× 34 333
José María Villagrán Moreno Spain 9 196 1.0× 77 1.2× 151 2.9× 40 1.1× 27 0.8× 36 426
Mian-Yoon Chong Taiwan 11 192 0.9× 17 0.3× 118 2.3× 21 0.6× 46 1.4× 15 342
Jacqueline Feldman United States 8 136 0.7× 24 0.4× 54 1.0× 36 1.0× 24 0.7× 20 277

Countries citing papers authored by Dolores Keating

Since Specialization
Citations

This map shows the geographic impact of Dolores Keating's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dolores Keating with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dolores Keating more than expected).

Fields of papers citing papers by Dolores Keating

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dolores Keating. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dolores Keating. The network helps show where Dolores Keating may publish in the future.

Co-authorship network of co-authors of Dolores Keating

This figure shows the co-authorship network connecting the top 25 collaborators of Dolores Keating. A scholar is included among the top collaborators of Dolores Keating based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dolores Keating. Dolores Keating is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keating, Dolores, et al.. (2025). Fighting fire with fire: the need to use metformin to combat antipsychotic-induced weight gain and metabolic complications. Irish Journal of Psychological Medicine. 1–7.
2.
Ramsay, Hugh, Liana Romaniuk, Jane McGrath, et al.. (2025). Stimulant Medication Use and Risk of Psychotic Experiences. PEDIATRICS. 155(6). 1 indexed citations
3.
Leigh, Greg, et al.. (2025). Exploring what works in mental health education for health profession students: a realist review. BMC Medical Education. 25(1). 673–673.
4.
5.
Keating, Dolores, et al.. (2024). What works for whom, how and why in mental health education for undergraduate health profession students? A realist synthesis protocol. BMJ Open. 14(3). e078130–e078130. 1 indexed citations
6.
Higgins, Agnès, Pat Bracken, Toto Gronlund, et al.. (2024). Identifying priorities for future research on reducing and stopping psychiatric medication: results of a James Lind Alliance priority-setting partnership. BMJ Open. 14(11). e088266–e088266. 4 indexed citations
7.
Keating, Dolores, Stephen McWilliams, Mary Clarke, & Judith Strawbridge. (2023). Pharmacy student attitudes to mental illness and the provision of mental health care: a repeated cross-sectional survey. International Journal of Clinical Pharmacy. 45(5). 1231–1240. 1 indexed citations
8.
Feeney, Larkin, et al.. (2023). Pharmacist-led medicines optimisation service in an inpatient mental health setting. Irish Journal of Psychological Medicine. 41(3). 393–400. 1 indexed citations
9.
McWilliams, Stephen, et al.. (2023). Cardiometabolic risk in people under 40 years with severe mental illness: reading between the guidelines. International Journal of Clinical Pharmacy. 45(5). 1299–1301. 1 indexed citations
10.
Keating, Dolores, Stephen McWilliams, Fiona Boland, et al.. (2022). The development and validation of a medicines optimisation tool to protect the physical health of people with severe mental illness (OPTIMISE). BMC Psychiatry. 22(1). 585–585. 6 indexed citations
11.
Keating, Dolores, Stephen McWilliams, Fiona Boland, et al.. (2021). Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study. BMJ Open. 11(1). e040387–e040387. 16 indexed citations
12.
Gorton, Hayley C., Ruth Edwards, Samar Farid, et al.. (2021). UK and Ireland survey of MPharm student and staff experiences of mental health curricula, with a focus on Mental Health First Aid. Journal of Pharmaceutical Policy and Practice. 14(1). 73–73. 6 indexed citations
13.
Gorton, Hayley C., Ruth Edwards, Samar Farid, et al.. (2021). Mental health curricula and Mental Health First Aid in the MPharm. International Journal of Pharmacy Practice. 29(Supplement_1). i37–i38. 3 indexed citations
14.
Murray, Séan, et al.. (2020). Clozapine use – has practice changed?. Journal of Psychopharmacology. 34(5). 567–573. 6 indexed citations
15.
Keating, Dolores, et al.. (2019). Pharmacy Students’ Reflections on an Experiential Learning Visit to a Psychiatric Hospital. American Journal of Pharmaceutical Education. 83(5). 6784–6784. 11 indexed citations
16.
Keating, Dolores, et al.. (2019). Patients and Caregivers Helping to Shape the Undergraduate Pharmacy Mental Health Curriculum. American Journal of Pharmaceutical Education. 83(9). 7138–7138. 9 indexed citations
17.
Keating, Dolores, et al.. (2019). Optimising prescribing for patients with severe mental illness: the need for criteria. Evidence-Based Mental Health. 22(4). 139–141. 6 indexed citations
18.
Doyle, Roisin, Caragh Behan, Donal O’Keeffe, et al.. (2017). Clozapine Use in a Cohort of First-Episode Psychosis. Journal of Clinical Psychopharmacology. 37(5). 512–517. 26 indexed citations
19.
Keating, Dolores, Stephen McWilliams, Ian Schneider, et al.. (2017). Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode. BMJ Open. 7(1). e013881–e013881. 91 indexed citations
20.
Keating, Dolores, Stephen McWilliams, Kevin Madigan, et al.. (2015). Glasgow Antipsychotic Side-effects Scale for Clozapine — Development and validation of a clozapine-specific side-effects scale. Schizophrenia Research. 168(1-2). 505–513. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter H. Hilderink Breakdown of academic impact, for papers by Wulf‐Peter Hansen Breakdown of academic impact, for papers by Alex Su Breakdown of academic impact, for papers by Mallik Greene Breakdown of academic impact, for papers by Sainza García Breakdown of academic impact, for papers by Ivano Caselli Breakdown of academic impact, for papers by Marta Ielmini Breakdown of academic impact, for papers by José María Villagrán Moreno Breakdown of academic impact, for papers by Mian-Yoon Chong Breakdown of academic impact, for papers by Jacqueline Feldman
Rankless by CCL
2026